Cargando…
COVID-19 and Cancer in Cuba
The COVID-19 pandemic has called attention to the contribution of comorbidities, including cancer and brought additional challenges to previously existing programs for cancer treatment and control. The COVID-19 pandemic in Cuba was addressed through an integrated all-society action plan that to date...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7413158/ https://www.ncbi.nlm.nih.gov/pubmed/32994047 http://dx.doi.org/10.1053/j.seminoncol.2020.07.009 |
_version_ | 1783568750999502848 |
---|---|
author | Rubio, Maria Caridad Sanchez, Lizet Abreu-Ruíz, Gisela Bermejo-Bencomo, Walkiria Crombet, Tania Lage, Agustin |
author_facet | Rubio, Maria Caridad Sanchez, Lizet Abreu-Ruíz, Gisela Bermejo-Bencomo, Walkiria Crombet, Tania Lage, Agustin |
author_sort | Rubio, Maria Caridad |
collection | PubMed |
description | The COVID-19 pandemic has called attention to the contribution of comorbidities, including cancer and brought additional challenges to previously existing programs for cancer treatment and control. The COVID-19 pandemic in Cuba was addressed through an integrated all-society action plan that to date has been largely successful with a low incidence of COVID-19 and mortality rates several-fold lower than worldwide averages. Despite downsizing many other health components all oncology services were maintained. Between March 11, when the first case was detected, until July 23, Cuba reported 2,449 cases of COVID-19 that included 28 (1.14%) with a diagnosis of cancer. Distribution among cancer diagnoses did not deviate from that expected according to cancer epidemiology in Cuba. However, although the probability of getting infected with the coronavirus for a cancer patient (0.012%), was not higher than that of the general population (0.020%), 9 of the 28 (32.1%) died, a lethality higher than that of COVID-19 patients without cancer (3.5%) a difference that is statistically significant (P< .001). We argue that going forward scientific research on the relationship of aging, inflammation and cancer, including identification of biomarkers and the development of novel therapeutic interventions, should become one of the priorities in the post-COVID agenda of both oncologists and infectious disease scientists. |
format | Online Article Text |
id | pubmed-7413158 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Published by Elsevier Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-74131582020-08-10 COVID-19 and Cancer in Cuba Rubio, Maria Caridad Sanchez, Lizet Abreu-Ruíz, Gisela Bermejo-Bencomo, Walkiria Crombet, Tania Lage, Agustin Semin Oncol Article The COVID-19 pandemic has called attention to the contribution of comorbidities, including cancer and brought additional challenges to previously existing programs for cancer treatment and control. The COVID-19 pandemic in Cuba was addressed through an integrated all-society action plan that to date has been largely successful with a low incidence of COVID-19 and mortality rates several-fold lower than worldwide averages. Despite downsizing many other health components all oncology services were maintained. Between March 11, when the first case was detected, until July 23, Cuba reported 2,449 cases of COVID-19 that included 28 (1.14%) with a diagnosis of cancer. Distribution among cancer diagnoses did not deviate from that expected according to cancer epidemiology in Cuba. However, although the probability of getting infected with the coronavirus for a cancer patient (0.012%), was not higher than that of the general population (0.020%), 9 of the 28 (32.1%) died, a lethality higher than that of COVID-19 patients without cancer (3.5%) a difference that is statistically significant (P< .001). We argue that going forward scientific research on the relationship of aging, inflammation and cancer, including identification of biomarkers and the development of novel therapeutic interventions, should become one of the priorities in the post-COVID agenda of both oncologists and infectious disease scientists. Published by Elsevier Inc. 2020-10 2020-08-07 /pmc/articles/PMC7413158/ /pubmed/32994047 http://dx.doi.org/10.1053/j.seminoncol.2020.07.009 Text en © 2020 Published by Elsevier Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Rubio, Maria Caridad Sanchez, Lizet Abreu-Ruíz, Gisela Bermejo-Bencomo, Walkiria Crombet, Tania Lage, Agustin COVID-19 and Cancer in Cuba |
title | COVID-19 and Cancer in Cuba |
title_full | COVID-19 and Cancer in Cuba |
title_fullStr | COVID-19 and Cancer in Cuba |
title_full_unstemmed | COVID-19 and Cancer in Cuba |
title_short | COVID-19 and Cancer in Cuba |
title_sort | covid-19 and cancer in cuba |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7413158/ https://www.ncbi.nlm.nih.gov/pubmed/32994047 http://dx.doi.org/10.1053/j.seminoncol.2020.07.009 |
work_keys_str_mv | AT rubiomariacaridad covid19andcancerincuba AT sanchezlizet covid19andcancerincuba AT abreuruizgisela covid19andcancerincuba AT bermejobencomowalkiria covid19andcancerincuba AT crombettania covid19andcancerincuba AT lageagustin covid19andcancerincuba |